Discover
CGEM
Cullinan Therapeutics, Inc.
17.28
2 x 13.20
2 x 22.19
bid
ask
-
0.93
5.11%
2 @ 04:53 AM
17.54 +0.26 (1.48%)
| Ytd | 66.96% | |
| 1y | 126.18% |
17.27
day range
18.47
5.68
52 week range
19.43
| Open | 18.05 | Prev Close | 18.21 | Low | 17.27 | High | 18.47 | Mkt Cap | 1.06B |
| Vol | 737.53K | Avg Vol | 1.08M | EPS | -3.37 | P/E | N/A | Forward P/E | -6.84 |
| Beta | 0.01 | Short Ratio | 6.74 | Inst. Own | 107.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 14.94 | 200-d Avg | 11.86 | 1yr Est | 31.55 |
| Income Statement | |||
| Operating Expenses | 53.70M | ||
| Research and Development Expense | 42.12M | ||
| Selling, General and Administrative Expense | 11.57M | ||
| Operating Income | -53.70M | ||
| Net Income | -49.66M | ||
| Net Income Common Stock | -49.66M | ||
| Net Income Common Stock (USD) | -49.66M | ||
| Consolidated Income | -49.66M | ||
| Earnings per Basic Share | -0.75 | ||
| Earnings per Basic Share (USD) | -0.75 | ||
| Earnings per Diluted Share | -0.75 | ||
| Earning Before Interest & Taxes (EBIT) | -49.66M | ||
| Earning Before Interest & Taxes (USD) | -49.66M | ||
| Preferred Dividends Income Statement Impact | 562.52K | ||
| Weighted Average Shares | 60.46M | ||
| Weighted Average Shares Diluted | 60.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 75.08M | ||
| Cash and Equivalents (USD) | 75.08M | ||
| Investments | 315.31M | ||
| Investments Current | 276.80M | ||
| Investments Non-Current | 38.50M | ||
| Current Assets | 361.41M | ||
| Property, Plant & Equipment Net | 2.78M | ||
| Total Assets | 402.98M | ||
| Debt Current | 725.00K | ||
| Total Debt | 2.38M | ||
| Current Liabilities | 35.15M | ||
| Debt Non-Current | 1.66M | ||
| Total Liabilities | 36.81M | ||
| Accumulated Retained Earnings (Deficit) | -637.78M | ||
| Accumulated Other Comprehensive Income | 127.00K | ||
| Shareholders Equity | 366.17M | ||
| Shareholders Equity (USD) | 366.17M | ||
| Assets Non-Current | 41.58M | ||
| Total Debt (USD) | 2.38M | ||
| Liabilities Non-Current | 1.66M | ||
| Trade and Non-Trade Payables | 2.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 79.00K | ||
| Net Cash Flow from Financing | 380.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -13.25M | ||
| Issuance (Purchase) of Equity Shares | 380.00K | ||
| Net Cash Flow from Investing | 32.41M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 32.41M | ||
| Net Cash Flow from Operations | -46.04M | ||
| Share Based Compensation | 7.62M | ||